Skip to main content

Table 2 Differences in weight gain velocities for children admitted with edematous compared to non-edematous severe acute malnutrition during the stabilization, transition and rehabilitation phases of inpatient therapeutic care, and during outpatient therapeutic care†

From: Weight and mid-upper arm circumference gain velocities during treatment of young children with severe acute malnutrition, a prospective study in Uganda

    Unadjusted Age-sex adjusted Edema x time
  Time n b (95%CI) b (95%CI) P-value
Stabilization Day 2 360 0.72 (−8.43; 9.87) 0.75 (− 8.45; 9.95) 0.315
Day 3 351 − 11.27 (−20.68; − 1.85)* − 11.26 (− 20.73; − 1.79)*  
Day 4 319 − 13.10 (− 23.12; − 3.08)* − 13.09 (− 23.15; − 3.02)*  
Day 5 283 −4.61 (− 15.22; 6.00) − 4.63 (− 15.27; 6.02)  
Day 6 250 − 9.78 (− 20.96; 1.40) − 9.82 (− 21.04; 1.40)  
Day 7 209 −7.63 (− 19.80; 4.55) −7.66 (− 19.87; 4.55)  
Day 8 179 − 11.91 (− 25.85; 2.02) −12.02 (− 26.00; 1.96)  
Transition Day 1 302 −1.77 (−9.81; 6.29) − 1.70 (− 9.85; 6.45) 0.918
Day 2 258 − 2.40 (− 11.01; 6.23) − 2.33 (− 11.05; 6.38)  
Day 3 201 1.10 (− 8.57; 10.77) 1.14 (− 8.58; 10.86)  
Day 4 146 0.74 (−10.70; 12.18) 0.79 (−10.71; 12.30)  
Rehabilitation Day 1 282 −0.65 (−9.12; 7.82) − 0.21 (−8.77; 8.34) 0.995
Day 2 258 −0.46 (−9.36; 8.42) − 0.11 (− 9.057; 8.84)  
Day 3 231 1.25 (−8.14; 10.63) 1.57 (−7.86; 11.00)  
Day 4 171 −2.65 (− 13.31; 8.01) −2.31 (− 13.01; 8.39)  
Day 5 117 −2.19 (−15.06; 10.69) −1.90 (− 14.80; 11.01)  
Outpatient Week 2 295 1.90 (0.84; 2.95)* 2.09 (1.03; 3.15) * 0.002
Week 4 285 −0.70 (−1.77; 0.37) −0.49 (− 1.57; 0.58)  
Week 6 284 −0.64 (−1.71; 0.43) − 0.44 (− 1.52; 0.64)  
Week 8 284 −0.50 (−1.58; 0.58) − 0.31 (− 1.39; 0.77)  
Week 10 27 −0.43 (−3.40; 2.94) − 0.31 (− 3.67; 3.05)  
Week 12 19 2.55 (−1.47; 6.58) 2.75 (−1.27; 6.76)  
  1. Data are number (n), regression coefficients (b) and 95% confidence intervals (CI). *P < 0.05. During ITC, numbers are varying each day because children are transferred from one phase to another based on condition. During OTC, there are small variations in numbers analyzed (week 2–8) because of missing data. After 8 weeks, the numbers are very few because follow-up was ended at 8 weeks for those who had recovered